Proquad Market Report 2026

Proquad Market Overview

• The Proquad market growth in the historic period has been driven by expansion of routine childhood vaccination programs, increasing public health awareness initiatives • Market expansion is supported by expansion of global vaccination coverage targets, rising investments in next-generation vaccine development • Growth Driver: Rising Incidence Of Measles And Chickenpox Driving Market Growth Due To Increasing Vaccine Demand And Public Health Initiatives • Market Trend: Role Of Intramuscular Administration In Improving Vaccine Delivery Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Proquad Market?

Proquad is a vaccine designed to protect against measles, mumps, rubella (MMR), and varicella (chickenpox). It is a combination vaccine, meaning it combines multiple vaccines into one shot to reduce the number of injections needed for immunization. It is used primarily in children, typically administered as a single dose for those between 12 months and 12 years of age. The main types of indications for proquad include measles, mumps, rubella, and varicella. The measles segment focuses on vaccines specifically designed to prevent measles, a highly contagious viral disease, administered in childhood and is part of the MMR (measles, mumps, and rubella) combination vaccine. The patient types include pediatric patients and adult patients and used by various end users such as healthcare providers, pharmacies, and public health organizations.

What Is The Proquad Market Growth Forecast?

The growth in the forecast period can be attributed to expansion of global vaccination coverage targets, rising investments in next-generation vaccine development, increasing focus on immunization compliance monitoring, growth of public-private vaccination partnerships, improving vaccine distribution logistics. Major trends in the forecast period include increasing adoption of combination vaccines, rising focus on pediatric immunization coverage, expansion of national immunization programs, growing emphasis on cold chain optimization, improved vaccine safety and monitoring systems.

Global Proquad Market Segmentation

1) By Indication: Measles, Mumps, Rubella, Varicella 2) By Patient Type: Pediatric Patient, Adult Patient 3) By End User: Healthcare Providers, Pharmacies, Public Health Organization

What Are The Drivers Of The Proquad Market?

The rising incidence of measles and chickenpox is expected to propel the growth of the proquad market going forward. Measles is a highly contagious viral infection characterized by fever, cough, and a red rash, preventable through vaccination, while chickenpox is a contagious disease caused by the Varicella-zoster virus, marked by an itchy blister-like rash and preventable with a vaccine. Measles and chickenpox cases are rising due to declining vaccination rates, misinformation about vaccines, increased global travel, and outbreaks in unvaccinated populations, leading to the re-emergence of these preventable diseases. Proquad, a combination vaccine for measles, mumps, rubella, and varicella (chickenpox), helps protect against these diseases by providing immunity through a single dose, reducing the risk of infection, controlling outbreaks, and ensuring comprehensive coverage to prevent complications associated with measles and chickenpox. For instance, in May 2024, according to the World Health Organization, a Switzerland-based non-profit organization, 56,634 measles cases and four deaths were officially reported across 45 out of 53 countries in the WHO European Region during the first three months of 2024. Throughout 2023, 61,070 cases and 13 deaths were reported by 41 countries. Therefore, the rising incidence of measles and chickenpox is driving the growth of the proquad industry. Increasing healthcare expenditures are anticipated to fuel the growth of the proquad market. Healthcare expenditures refer to the total amount spent on healthcare-related services, products, and activities within a specified period, typically on an individual, community, national, or global level. Increasing healthcare expenditures are driven by factors such as the rising prevalence of chronic diseases, an aging population, advancements in medical technology, and growing demand for more advanced treatments and healthcare services. Healthcare expenditures support proquad by funding immunization programs, enhancing accessibility, promoting public awareness, and ensuring the infrastructure and insurance coverage needed for its widespread adoption and efficacy. For instance, in May 2023, the Office for National Statistics, a UK-based government department, reported that in 2023, healthcare expenditure in the UK was approximately $362 billion (£292 billion), reflecting a nominal increase of 5.6%. Additionally, long-term health and social care expenditure rose by 2.8% in real terms in 2022. Therefore, increasing healthcare expenditure is driving the growth of the proquad industry.

Key Players In The Global Proquad Market

Major companies operating in the proquad market are Merck and Co. Inc.

Global Proquad Market Trends and Insights

Key companies in the proquad market are the focus on expansion of vaccine administration options such as intramuscular (IM) administration to enhance convenience and consistency in immunization practices. Intramuscular (IM) administration refers to the delivery of a vaccine or medication directly into the muscle tissue, allowing for faster absorption into the bloodstream. For instance, in March 2023, Merck & Co. Inc., a US-based pharmaceutical company, received U.S. Food and Drug Administration (FDA) approval for the addition of an intramuscular (IM) administration option to the U.S. Product Insert (USPI) for its MMRV vaccine family, including ProQuad. With this approval, the MMRV family joins other commonly recommended vaccines that can be given intramuscularly. Healthcare professionals in the U.S. now have the option to administer all routinely recommended injectable pediatric vaccines in the CDC immunization schedule via the same IM route. M-M-R II, VARIVAX, and ProQuad are the only measles, mumps, rubella, and varicella vaccines approved for IM administration in the U.S. The MMRV family of vaccines is also licensed for IM use in the European Union.

Regional Insights

North America was the largest region in the proquad market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Proquad Market?

The proquad market consists of sales of proquad lyophilized suspension for injection, subcutaneous injection and intramuscular injection. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Proquad Market Report 2026?

The proquad market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the proquad industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.